Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2024-12-19 00:00:00 ET · period of report 2024-12-17 · accession 0000914475-24-000224 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-19 | 2024-12-17 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $79.02 | +1,091 | 3,598 | +44% | +$86.2K |
| D | 2024-12-19 | 2024-12-17 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $135.00 | -1,091 | 2,507 | -30% | -$147.3K |
| D | 2024-12-19 | 2024-12-17 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $0.00 | -1,091 | 2,990 | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-17 | M | A | 1,091 | $79.02 | 3,598 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-17 | S | D | 1,091 | $135.00 | 2,507 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option | 2024-12-17 | M | D | 1,091 | $0.00 | 2,990 | D | $79.02 · — to 2032-01-31 | 1,091 Common Stock | (F2) The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022. These options will expire ten years from the date of grant on January 31, 2032. |